Gene Therapy & Gene Editing
Part of Healthcare - Genomics & Precision Medicine
 VRTX | Vertex Pharmaceuticals Inc | $113.6b | $489.29 | +2.3% | 3.0M |
 REGN | Regeneron Pharmaceuticals Inc | $64.5b | $629.25 | +2.1% | 689.1K |
 INSM | Insmed, Inc. | $23.2b | $104.75 | -0.9% | 3.4M |
 BMRN | BioMarin Pharmaceuticals Inc | $11.1b | $59.30 | +2.9% | 1.9M |
 KRYS | Krystal Biotech, Inc. Common Stock | $9.1b | $366.76 | +3.3% | 464.7K |
 CRSP | CRISPR Therapeutics AG | $5.4b | $54.52 | +1.7% | 1.7M |
 FOLD | Amicus Therapeutics, Inc | $4.5b | $14.49 | +0.0% | 3.5M |
 BEAM | Beam Therapeutics Inc. Common Stock | $3.4b | $35.19 | +2.6% | 2.6M |
 NTLA | Intellia Therapeutics, Inc | $2.0b | $16.63 | +3.9% | 4.4M |
 SRPT | Sarepta Therapeutics,, Inc. Common Stock | $1.9b | $16.90 | +5.2% | 3.8M |
 QURE | uniQure N.V. | $1.8b | $47.66 | -3.1% | 2.8M |
 VCEL | Vericel Corporation | $1.7b | $46.26 | +7.7% | 1.2M |
 TSHA | Taysha Gene Therapies, Inc. Common Stock | $1.7b | $6.28 | +2.3% | 3.7M |
 PGEN | Precigen, Inc. Common Stock | $1.5b | $5.82 | +6.2% | 5.8M |
 BLFS | BioLife Solutions Inc. | $1.2b | $29.75 | +4.2% | 2.4M |
 MGTX | MeiraGTx Holdings plc Ordinary Shares | $1.0b | $12.10 | +4.7% | 884.2K |
 SANA | Sana Biotechnology, Inc. Common Stock | $0.9b | $3.44 | +4.6% | 3.1M |
 PCRX | Pacira BioSciences, Inc. Common Stock | $0.9b | $25.25 | +3.4% | 502.5K |
 CYRX | CryoPort, Inc. Common Stock | $0.8b | $15.97 | +0.9% | 559.4K |
 ALLO | Allogene Therapeutics, Inc. Common Stock | $0.7b | $2.13 | +2.9% | 7.6M |
 SLDB | Solid Biosciences Inc. Common Stock | $0.7b | $9.12 | +4.6% | 1.6M |
 DSGN | Design Therapeutics, Inc. Common Stock | $0.7b | $13.36 | -1.0% | 788.7K |
 PRME | Prime Medicine, Inc. Common Stock | $0.6b | $3.44 | +7.9% | 4.1M |
 CABA | Cabaletta Bio, Inc. Common Stock | $0.6b | $3.03 | +3.8% | 7.4M |
 EDIT | Editas Medicine, Inc. Common Stock | $0.5b | $2.79 | +4.4% | 2.0M |
 FDMT | 4D Molecular Therapeutics, Inc. Common Stock | $0.5b | $11.36 | +0.9% | 1.1M |
 KYTX | Kyverna Therapeutics, Inc. Common Stock | $0.5b | $8.29 | +3.0% | 822.2K |
 OCGN | Ocugen, Inc. Common Stock | $467.2m | $1.50 | +8.4% | 12.4M |
 NGNE | Neurogene, Inc. Common Stock | $447.8m | $32.03 | +5.4% | 317.7K |
 LXEO | Lexeo Therapeutics, Inc. Common Stock | $403.6m | $4.76 | +1.4% | 506.4K |
 BNTC | Benitec Biopharma Inc. Common Stock | $397.1m | $12.37 | -4.2% | 229.0K |
 RGNX | REGENXBIO Inc. | $362.4m | $10.46 | +2.7% | 2.0M |
 IRD | Opus Genetics, Inc. Common Stock | $354.9m | $4.02 | +7.5% | 1.4M |
 RCKT | Rocket Pharmaceuticals, Inc. Common Stock | $335.2m | $3.27 | 0.0% | 3.3M |
 ABEO | Abeona Therapeutics Inc. Common Stock | $329.4m | $5.62 | +1.1% | 1.4M |
 TRDA | Entrada Therapeutics, Inc. Common Stock | $274.5m | $7.74 | +8.0% | 665.2K |
 CRBU | Caribou Biosciences, Inc. Common Stock | $234.1m | $1.67 | +6.4% | 2.0M |
 VYGR | Voyager Therapeutics, Inc. Common Stock | $233.8m | $3.58 | +0.8% | 821.2K |
 KRRO | Korro Bio, Inc. Common Stock | $193.4m | $12.66 | +4.1% | 164.1K |
 TNYA | Tenaya Therapeutics, Inc. Common Stock | $188.6m | $0.72 | +1.1% | 1.2M |
 DTIL | Precision BioSciences, Inc. Common Stock | $179.8m | $7.26 | +8.4% | 482.9K |
 GNLX | Genelux Corporation Common Stock | $136.8m | $3.23 | -1.0% | 303.6K |
 MXCT | MaxCyte, Inc. Common Stock | $129.6m | $1.21 | -1.6% | 2.0M |
 ENGN | enGene Therapeutics Inc. Common Stock | $123.9m | $1.75 | -1.1% | 1.2M |
 CBUS | Cibus, Inc. Class A Common Stock | $109.9m | $1.35 | 0.0% | 204.4K |
 INO | Inovio Pharmaceuticals, Inc. | $107.8m | $1.10 | +0.9% | 1.1M |
 SGMO | Sangamo Therapeutics, Inc. Common Stock | $83.3m | $0.18 | -17.5% | 6.9M |
 TCRX | TScan Therapeutics, Inc. Common Stock | $70.6m | $0.91 | +14.7% | 651.5K |
 TIL | Instil Bio, Inc. Common Stock | $54.7m | $7.44 | 0.0% | 14.9K |
 MGX | Metagenomi Therapeutics, Inc. Common Stock | $51.2m | $1.25 | +5.0% | 178.5K |